Drug
CDP-Choline
CDP-Choline is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Phase Distribution
Ph phase_3
1
20%
Ph phase_2
4
80%
Phase Distribution
0
Early Stage
4
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
4(80.0%)
Phase 3Large-scale testing
1(20.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Other(2)
Detailed Status
Completed3
unknown2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 24 (80.0%)
Phase 31 (20.0%)
Trials by Status
unknown240%
completed360%
Recent Activity
0 active trials
Showing 5 of 5
unknownphase_2
CDP-choline Treatment in ATS Users
NCT02630069
completedphase_2
Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia
NCT00509067
completedphase_2
CDP-Choline and Working Memory After TBI: A Neuroimaging Study
NCT00727246
unknownphase_2
Effects of CDP-Choline on Gating and Cognitive Deficits in First Episode Schizophrenia
NCT02088983
completedphase_3
Efficacy and Safety of CDP-choline in Patients With Methamphetamine Dependence
NCT01007539
Clinical Trials (5)
Showing 5 of 5 trials
NCT02630069Phase 2
CDP-choline Treatment in ATS Users
NCT00509067Phase 2
Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia
NCT00727246Phase 2
CDP-Choline and Working Memory After TBI: A Neuroimaging Study
NCT02088983Phase 2
Effects of CDP-Choline on Gating and Cognitive Deficits in First Episode Schizophrenia
NCT01007539Phase 3
Efficacy and Safety of CDP-choline in Patients With Methamphetamine Dependence
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5